Outset Medical Past Earnings Performance
Past criteria checks 0/6
Outset Medical's earnings have been declining at an average annual rate of -19.3%, while the Medical Equipment industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 26.8% per year.
Key information
-19.3%
Earnings growth rate
72.8%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 26.8% |
| Return on equity | -294.7% |
| Net Margin | -122.8% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
A Piece Of The Puzzle Missing From Outset Medical, Inc.'s (NASDAQ:OM) 44% Share Price Climb
Dec 23
Further Upside For Outset Medical, Inc. (NASDAQ:OM) Shares Could Introduce Price Risks After 32% Bounce
Nov 08Outset Medical, Inc. (NASDAQ:OM) Might Not Be As Mispriced As It Looks After Plunging 27%
Sep 24Outset Medical, Inc. (NASDAQ:OM) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Aug 11Outset Medical, Inc. (NASDAQ:OM) Stock Rockets 25% But Many Are Still Ignoring The Company
Jul 17Outset Medical: Expecting Accelerated Growth And Reduced Cash Burn Going Forward
May 28Outset Medical, Inc.'s (NASDAQ:OM) CEO Compensation Is Looking A Bit Stretched At The Moment
May 23Investors Still Aren't Entirely Convinced By Outset Medical, Inc.'s (NASDAQ:OM) Revenues Despite 30% Price Jump
May 10Not Many Are Piling Into Outset Medical, Inc. (NASDAQ:OM) Stock Yet As It Plummets 29%
Feb 14Outset Medical, Inc.'s (NASDAQ:OM) Earnings Haven't Escaped The Attention Of Investors
Jun 09Outset Medical: Tablo Ship Hold A Key Overhang To Unlock Risk Capital
Sep 20Outset Medical awarded VA contract for hemodialysis
Aug 15Outset Medical jumps 24% after 2Q results as FDA clears hemodialysis system
Aug 01Outset Medical: Margins Leave No Tangible Value Flow, Pricing 18% Downside
Jul 06Revenue & Expenses Breakdown
How Outset Medical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 115 | -141 | 121 | 43 |
| 30 Jun 24 | 116 | -159 | 132 | 51 |
| 31 Mar 24 | 125 | -169 | 138 | 56 |
| 31 Dec 23 | 130 | -173 | 141 | 57 |
| 30 Sep 23 | 132 | -176 | 143 | 56 |
| 30 Jun 23 | 129 | -170 | 138 | 53 |
| 31 Mar 23 | 118 | -170 | 136 | 52 |
| 31 Dec 22 | 115 | -163 | 130 | 49 |
| 30 Sep 22 | 112 | -163 | 129 | 49 |
| 30 Jun 22 | 110 | -152 | 120 | 45 |
| 31 Mar 22 | 110 | -139 | 109 | 40 |
| 31 Dec 21 | 103 | -132 | 101 | 37 |
| 30 Sep 21 | 92 | -123 | 93 | 33 |
| 30 Jun 21 | 79 | -135 | 96 | 33 |
| 31 Mar 21 | 66 | -131 | 87 | 31 |
| 31 Dec 20 | 50 | -79 | 76 | 29 |
| 30 Sep 20 | 40 | -67 | 60 | 28 |
| 30 Jun 20 | 29 | -41 | 42 | 24 |
| 31 Mar 20 | 20 | -40 | 34 | 24 |
| 31 Dec 19 | 15 | -85 | 29 | 23 |
| 31 Dec 18 | 2 | -73 | 18 | 23 |
Quality Earnings: OM is currently unprofitable.
Growing Profit Margin: OM is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: OM is unprofitable, and losses have increased over the past 5 years at a rate of 19.3% per year.
Accelerating Growth: Unable to compare OM's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: OM is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (12.9%).
Return on Equity
High ROE: OM has a negative Return on Equity (-294.71%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 10:06 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Outset Medical, Inc. is covered by 11 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Travis Steed | BofA Global Research |
| Michael Gorman | BTIG |
| Marie Thibault | BTIG |